跳至主要内容
临床试验/EUCTR2018-004899-35-Outside-EU/EEA
EUCTR2018-004899-35-Outside-EU/EEA进行中(未招募)1 期

A Phase 3, Multicenter, Open Label Trial to Evaluate the Long-term Safety and Tolerability of Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.0 个研究点开始时间: 2024年6月13日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 5 to 17 year of age or turned 18 while enrolled in the 331-201-00148 study
  • Autism Spectrum Disorder
  • Completion of 331-201-00148 trial
  • Investigator assessment
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 95
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range 1
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Did not complete treatment period or incurred significant protocol deviations during 331-201-00148 study
  • Sexually active males or female of childbearing potential who do not agree to practice 2 different methods of birth control or remain abstinent during the trial and for 30 days after the last dose
  • Female with positive pregnancy test

研究者

相似试验

进行中(未招募)
1 期
A Clinical Study to Investigate the Long-Term Safety and Effectiveness of Repeat Treatments of DaxibotulinumtoxinA for Injection in subjects with Isolated Cervical Dystonia (ASPEN-OLS)Cervical DystoniaMedDRA version: 21.0 Level: LLT Classification code 10064124 Term: Cervical dystonia System Organ Class: 100000004859
EUCTR2018-000447-11-GBRevance Therapeutics Inc350
进行中(未招募)
1 期
A Clinical Study to Investigate the Long-Term Safety and Effectiveness of Repeat Treatments of DaxibotulinumtoxinA for Injection in subjects with Isolated Cervical Dystonia (ASPEN-OLS)Cervical DystoniaMedDRA version: 21.0Level: LLTClassification code 10064124Term: Cervical dystoniaSystem Organ Class: 100000004859
EUCTR2018-000447-11-ATRevance Therapeutics Inc350
进行中(未招募)
1 期
A Clinical Study to Investigate the Long-Term Safety and Effectiveness of Repeat Treatments of DaxibotulinumtoxinA for Injection in subjects with Isolated Cervical Dystonia (ASPEN-OLS)Cervical DystoniaMedDRA version: 21.0Level: LLTClassification code 10064124Term: Cervical dystoniaSystem Organ Class: 100000004859
EUCTR2018-000447-11-ITRevance Therapeutics, Inc350
招募中
2 期
Phase 2/3, Multicenter, Open-label Trial to Evaluate the Long-term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A NephropathyImmunoglobulin A Nephropathy
SLCTR/2022/028Otsuka Pharmaceutical Development & Commercialization, Inc.600
招募中
2 期
Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy
JPRN-jRCT2031220273Yano Hisako600